Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders

Purpose: To quantitatively investigate the correlation between liver fat content and hepatic perfusion disorders (HPD) after radiofrequency ablation (RFA) for liver cancer using magnetic resonance imaging (MRI)-determined proton density fat fraction (PDFF). Materials and methods: A total of 150 live...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li-Shan Shen, Quan-Xi Li, Xiao-Wen Luo, Hui-Jun Tang, You-Jie Tang, Wen-Jie Tang, Ruo-Mi Guo
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/7ddcf0867752492f92c64fc0dc9cd417
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7ddcf0867752492f92c64fc0dc9cd417
record_format dspace
spelling oai:doaj.org-article:7ddcf0867752492f92c64fc0dc9cd4172021-11-25T17:21:56ZQuantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders10.3390/diagnostics111121372075-4418https://doaj.org/article/7ddcf0867752492f92c64fc0dc9cd4172021-11-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/2137https://doaj.org/toc/2075-4418Purpose: To quantitatively investigate the correlation between liver fat content and hepatic perfusion disorders (HPD) after radiofrequency ablation (RFA) for liver cancer using magnetic resonance imaging (MRI)-determined proton density fat fraction (PDFF). Materials and methods: A total of 150 liver cancer patients underwent liver MRI examination within one month after RFA and at four months after RFA. According to the liver fat content, they were divided into non-, mild, moderate, and severe fatty liver groups. The liver fat content and hepatic perfusion disorders were determined using PDFF images and dynamic contrast-enhanced MRI images. The relationship between the liver fat content and HPD was investigated. Results: At the first postoperative MRI examination, the proportion of patients in the nonfatty liver group with hyperperfused foci (11.11%) was significantly lower than that in the mild (30.00%), moderate (42.86%), and severe fatty liver (56.67%) groups (<i>p</i> < 0.05), whereas the proportions of patients with hypoperfused foci (6.67%, 7.5%, 5.71%, and 6.67%, respectively) were not significantly different among the four groups (<i>p</i> > 0.05). In the nonfatty liver group, the liver fat content was not correlated with hyperperfusion abnormalities or hypoperfusion abnormalities. By contrast, in the three fatty liver groups, the liver fat content was correlated with hyperperfusion abnormalities but was not correlated with hypoperfusion abnormalities. At the second postoperative MRI examination, six patients in the nonfatty liver group were diagnosed with fatty liver, including two patients with newly developed hyperperfusion abnormalities and one patient whose hypoperfusion abnormality remained the same as it was in the first postoperative MRI examination. Conclusion: There was a high correlation between the liver fat content and hyperperfusion abnormalities after RFA for liver cancer. The higher the liver fat content was, the higher the was risk of hyperperfusion abnormalities. However, there was little correlation between liver fat content and hypoperfusion abnormalities, and the increase in postoperative liver fat content did not induce or alter the presence of hypoperfused foci.Li-Shan ShenQuan-Xi LiXiao-Wen LuoHui-Jun TangYou-Jie TangWen-Jie TangRuo-Mi GuoMDPI AGarticlefatty liverhepatic perfusion disordersmagnetic resonance imagingfat quantificationMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 2137, p 2137 (2021)
institution DOAJ
collection DOAJ
language EN
topic fatty liver
hepatic perfusion disorders
magnetic resonance imaging
fat quantification
Medicine (General)
R5-920
spellingShingle fatty liver
hepatic perfusion disorders
magnetic resonance imaging
fat quantification
Medicine (General)
R5-920
Li-Shan Shen
Quan-Xi Li
Xiao-Wen Luo
Hui-Jun Tang
You-Jie Tang
Wen-Jie Tang
Ruo-Mi Guo
Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
description Purpose: To quantitatively investigate the correlation between liver fat content and hepatic perfusion disorders (HPD) after radiofrequency ablation (RFA) for liver cancer using magnetic resonance imaging (MRI)-determined proton density fat fraction (PDFF). Materials and methods: A total of 150 liver cancer patients underwent liver MRI examination within one month after RFA and at four months after RFA. According to the liver fat content, they were divided into non-, mild, moderate, and severe fatty liver groups. The liver fat content and hepatic perfusion disorders were determined using PDFF images and dynamic contrast-enhanced MRI images. The relationship between the liver fat content and HPD was investigated. Results: At the first postoperative MRI examination, the proportion of patients in the nonfatty liver group with hyperperfused foci (11.11%) was significantly lower than that in the mild (30.00%), moderate (42.86%), and severe fatty liver (56.67%) groups (<i>p</i> < 0.05), whereas the proportions of patients with hypoperfused foci (6.67%, 7.5%, 5.71%, and 6.67%, respectively) were not significantly different among the four groups (<i>p</i> > 0.05). In the nonfatty liver group, the liver fat content was not correlated with hyperperfusion abnormalities or hypoperfusion abnormalities. By contrast, in the three fatty liver groups, the liver fat content was correlated with hyperperfusion abnormalities but was not correlated with hypoperfusion abnormalities. At the second postoperative MRI examination, six patients in the nonfatty liver group were diagnosed with fatty liver, including two patients with newly developed hyperperfusion abnormalities and one patient whose hypoperfusion abnormality remained the same as it was in the first postoperative MRI examination. Conclusion: There was a high correlation between the liver fat content and hyperperfusion abnormalities after RFA for liver cancer. The higher the liver fat content was, the higher the was risk of hyperperfusion abnormalities. However, there was little correlation between liver fat content and hypoperfusion abnormalities, and the increase in postoperative liver fat content did not induce or alter the presence of hypoperfused foci.
format article
author Li-Shan Shen
Quan-Xi Li
Xiao-Wen Luo
Hui-Jun Tang
You-Jie Tang
Wen-Jie Tang
Ruo-Mi Guo
author_facet Li-Shan Shen
Quan-Xi Li
Xiao-Wen Luo
Hui-Jun Tang
You-Jie Tang
Wen-Jie Tang
Ruo-Mi Guo
author_sort Li-Shan Shen
title Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
title_short Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
title_full Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
title_fullStr Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
title_full_unstemmed Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
title_sort quantification of liver fat content after radiofrequency ablation for liver cancer: correlation with hepatic perfusion disorders
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/7ddcf0867752492f92c64fc0dc9cd417
work_keys_str_mv AT lishanshen quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT quanxili quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT xiaowenluo quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT huijuntang quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT youjietang quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT wenjietang quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
AT ruomiguo quantificationofliverfatcontentafterradiofrequencyablationforlivercancercorrelationwithhepaticperfusiondisorders
_version_ 1718412479654002688